Faculty - Ajaz Sheikh, M.D.

Associate Professor
Director, Clinical Neurophysiology Fellowship Program

Special Interests

Sleep Medicine
Intra Operative Monitoring
Epilepsy
Clinical Neurophysiology

Education

M.B.B.S: University of Kashmir, Government Medical College Srinagar, Srinagar, J&K, India 1998-2004

Internship: University of Toledo, Toledo, Ohio, U.S.A 2010-2011

Residency: Psychiatry- University of Kashmir, Government Medical College Srinagar, Srinagar, J&K, India 2005-2008;

Neurology- University of Toledo, Toledo, Ohio, U.S.A 2011-2014

Fellowship: Clinical Neurophysiology/ Epilepsy, University Hospitals Case Medical Center, Cleveland OH, U.S.A 2014-2015;

Sleep Medicine, Duke University Medical Center, Durham NC, USA 2015-2016

Certifications

Meeting Continuing Certification Requirements, 2024
ABPN Initial Certification in Epilepsy: Board Certified on 10/22/2018

ABPN Initial Certification in Sleep Medicine: Board Certified on 11/20/2017

American Board of Clinical Neurophysiology (ABCN) Certification in Advanced Central Clinical Neurophysiology with Added Competency in Intraoperative Monitoring 2016

ABPN Initial Certification in Clinical Neurophysiology 2015

ABPN Initial Certification in Neurology 2014

Awards and Honors

Alpha Omega Alpha Induction, 2023
American Academy of Neurology A.B. Baker Teaching Recognition Award, 2020
Recipient of the Outstanding Neurology Attending Award (given by the Neurology residents), 2018-2019

Recipient of Arnold P. Gold Foundation Humanism and Excellence in Teaching Award 2013, 2014

Recipient of the Outstanding Neurology Resident Teaching Award 2014

selected Publications

Papers
Park S, Doan J, Sheikh I, Sheikh, A, IgLON 5 Antibody Syndrome: Isolated Case of a Patient With Indolent Disease Progression and Unusual MRI Findings. (Published- February 17, 2021) Cureus 13(2): e13386. doi:10.7759/cureus.13386

Karim N, Sheikh, A,: A Rare, Unreported Cognitive Side Effect of Topiramate: Do We Know It All Yet?. Cureus. 2020 Nov 5;12(11):e11342. doi: 10.7759/cureus.11342. PMID: 33304678; PMCID: PMC7719466.

Salahuddin, H., Afreen, E., Sheikh, I. S., Lateef, S., Dawod, G., Daboul, J., Karim, N., Gharaibeh, K., Al-Chalabi, M., Park, S. and Castonguay, A.C., Ragheb Assaly, Fadi Safi, Marla Matal, Ajaz A. Sheikh, Gretchen Tietjen, Deepa Malaiyandi, Elysia James, Imran Ali, Syed F Zadi, A. Abdelwahed, Vieh Kung, Richard Burgess, Mouhammad A Jumaa. Neurological Predictors of Clinical Outcomes in Hospitalized Patients with COVID-19 (Front Neurol. 2020 Oct 30;11:585944. doi: 10.3389/fneur.2020.585944. PMID: 33193048; PMCID: PMC7662675.

Salahuddin H, Sheikh AA, Hussaini S, Verghese C, Tietjen GE. Ischemic Stroke after Plasmapheresis. Am J Med Sci. 2018 Oct;356(4):399-403.

Socio-demographic correlates of substance use disorder patients seeking de-addiction services in Kashmir India -A cross sectional study. Nazima Bashir, Ajaz Ahmad Sheikh, Sufoora Bilques and Muhammad Mudasir Firdosi. BJMP 2015;8(4):a833

Study of Quality of Life in Patients Suffering from Post-Traumatic Stress Disorder in Comparison to Patients Suffering from Major Depressive Disorder. Sheikh Ahmad A, Muhammad-Firdosi M, Rather YH, Margoob MA, Bashir N. The Malaysian Journal of Psychiatry. December 2014, 23(2): 52-62

Brucellosis Masquerading as Spondylodiscitis with Multiple Intervertebral Disc Prolapse. Syed Arshad Hussain Andrabi, Shamila Hamid, and Sheikh Ajaz. J Glob Infect Dis. 2012 Jul-Sep; 4(3): 184–185.

ADHD presenting as recurrent epistaxis: a case report. Rather YH, Sheikh AA, Sufi AR, Qureshi A A, Wani Z A, and Shaukat TS. Child and Adolescent Psychiatry and Mental Health. 2011; 5: 13.

Completed and current research projects

Principal Investigator: ENGAGE-E-001: A Double-Blind, Placebo-Controlled, Inpatient, Dose-Ranging Efficacy Study of Staccato Alprazolam (STAP-001) in Subjects with Epilepsy with a Predictable Seizure Pattern: Status-Current. Site: University of Toledo Medical Center

Co-Investigator: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Exploring the Efficacy, Safety, and Tolerability of Natalizumab (BG00002) as Adjunctive Therapy in Adult Subjects With Drug-Resistant Focal Epilepsy: Status-Current. Site: University of Toledo Medical Center

Co-Investigator: A Randomized, Double-Blind, Placebo-Controlled, Dose Finding Study To Evaluate The Efficacy And Safety Of Padsevonil As Adjunctive Treatment Of Focal-Onset Seizures In Adult Subjects With Drug-Resistant Epilepsy (ARISE): Status-Current. Site: University of Toledo Medical Center

Co-Investigator: A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 as Adjunctive Therapy in Focal-onset Epilepsy: Status- Current. Site: University of Toledo Medical Center

Co-investigator: 547-SSE-301: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate The Efficacy And Safety of SAGE -547 Injection In The Treatment Of Subjects With Super-Refractory Status Epilepticus: Status-completed. Site: University of Toledo Medical Center

Participated as an investigator, and completed following drug trials:

'A randomized double blind multicentric, study to evaluate the safety and efficacy of Paliperidone ER compared to Olanzapine in patients with schizophrenia': Study center- Department of Psychiatry, Government Medical College Srinagar, India.

Six weeks phase IV study of the antidepressant drug, Bupropion sustained release 150 mg (Bupron SR-Sun Pharmaceuticals) : Study center- Department of Psychiatry, Government Medical College Srinagar, India.

Six weeks phase IV trial on the antipsychotic drug, Amisulpride (Amazeo- Torrent Pharmaceuticals) 100mg: : Study center- Department of Psychiatry, Government Medical College Srinagar, India.

Department of Neurology